TELMA LNB 50 (Cilnidipine (10mg) + Metoprolol Succinate (50mg) + Telmisartan (40mg))

Telma-LNB 10mg/50mg/40mg Tablet ER is formulated as a combination therapy for the management of hypertension when monotherapy does not yield sufficient results. By effectively reducing elevated blood pressure, this medication plays a role in decreasing the likelihood of serious cardiovascular events such as heart attacks and strokes. It is advisable to take this medication at a consistent time each day, with or without food, based on a physician’s instructions. Continuing the treatment as directed is essential, as discontinuation can lead to a worsening of blood pressure levels, which often remain asymptomatic. Incorporating regular physical activity, maintaining a healthy weight, and adhering to a balanced diet can further support blood pressure management. Patients should be aware that side effects may include but are not limited to nausea, alterations in taste, throat infections, back discomfort, and swelling in the ankles. To alleviate ankle swelling, elevating the legs while seated may be beneficial. Additionally, it is important to limit dietary potassium intake and refrain from potassium supplements during the course of this treatment. Regular check-ups may be required to monitor blood pressure, kidney function, blood glucose levels, and electrolyte levels. Individuals with pre-existing liver or kidney conditions should inform their healthcare provider prior to starting this medication. Pregnant or nursing women should also seek medical advice before initiating treatment. It is important to disclose any concurrent medications being taken, especially those for hypertension or cardiovascular issues.